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The aim of this prospective, randomized study was to investigate the possibility of performing pleurodesis using a 
small percutaneous catheter (Cystofix@ catheter, CHlO, 65 cm) inserted at bedside in patients with recurrent 
malignant pleural effusion and to compare this catheter with a conventional large bore chest tube (CH24) placed in 
connection with diagnostic thoracoscopy. After drainage pleurodesis was performed with tetracycline as sclerosing 
agent. Of 18 evaluable consecutive patients (mean age 67.8 years) nine were randomized for pleurodesis with the 
small and nine for the large catheter. In the former group, the majority (seven of nine) did not find insertion of the 
catheter more unpleasant than thoracentesis. In the latter group only a few (two of nine) found insertion comparable 
with thoracentesis (PcO.05). All patients found the presence of the large catheter very or somewhat unpleasant (two 
and seven patients), whereas this was only the case for a few (no and two patients) treated with the small catheter 
(PcO.05). In the former group three patients required new thoracentesis, whereas this was only the case for two 
patients in the latter group (P>O.O5). No complications were seen. We conclude that pleurodesis in patients with 
recurrent malignant pleural effusion can be performed with a small percutaneous catheter (Cystofix@) with an effect 
similar to that obtained with a large-bore chest tube and with less discomfort for the patient. 
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Introduction 
Recurrent pleural effusion is common in patients with 
malignant pleural disease. Pleurodesis with a sclerosing 
agent through a chest tube is often effective in the treatment 
of these patients. However, both the insertion and the 
presence of the classically used large-bore chest tube are 
connected with discomfort for the patient. We therefore 
examined the possibility of performing pleurodesis with a 
small percutaneous catheter (Cystofix@, Braun, Germany) 
inserted at bedside and compared this catheter with a 
conventional large-bore chest tube placed in connection 
with diagnostic thoracoscopy. 
Subjects 
Twenty-one consecutive patients with recurrent pleural 
effusion and pleural fluid cytology positive for malignancy 
were included. Expected lifetime was >3 months. The 
indication for drainage and chemical pleurodesis was recur- 
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rent pleural effusion combined with dyspnoea. The study 
was approved by the local Ethical Committee and all 
patients gave informed consent. 
Design of the Study 
The patients were randomized to chemical pleurodesis with 
tetracycline using either a small percutaneous catheter 
[Cystofix@ catheter CHlO, 65 cm (Braun, Germany)] or a 
conventional large-bore chest tube (CH24, Lsvens Kemiske 
Fabrik, Denmark) placed in connection with thoracoscopy. 
The patients were randomized by lot the day before the 
procedure. The patients’ discomfort in connection with the 
tube and the pleurodesis was evaluated by a questionnaire. 
Clinical and roentgenographic control was performed at 
weeks 3, 6 and 9. Roentgenographic response to therapy 
was categorized as complete (no recurrence of pleural fluid), 
partial (slight reaccumulation with blunted costophrenic 
angle) or none (complete recurrence of pleural fluid). 
Clinical response to therapy was evaluated by the need for 
new thoracentesis, i.e. the combination of symptoms and 
chest X-ray showing increase in pleural fluid. All data 
were evaluated by the same physician, who was without 
knowledge of the result of the randomization. 
The Cystofix catheter was inserted into the pleural space 
using 1% lidocaine for local anaesthesia. A small stab 
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wound was made through the skin and the hollow needle 
containing the catheter was advanced percutaneously to the 
pleural space. The catheter was advanced into the pleural 
space and the needle removed by splitting it through its 
small cleft. Removal of pleural fluid was done by suction, if 
needed. 
The large-bore chest tube was placed in connection with 
medical diagnostic thoracoscopy. This procedure in our 
hands (1) and in general (2) has been described in detail 
elsewhere. In short, pneumothorax was established by 
passively insufflating air from the atmosphere after pre- 
medication with diazepam 10 mg p.o. and atropine 0.5 mg 
intramuscularly. Under local anaesthesia with 1% lidocaine 
the combined scope and forceps was inserted through a 
trocar in an intercostal space with the patient resting on the 
healthy side. Residual effusion was evacuated through a 
catheter, the pleural space was examined and biopsies were 
tak.en depending on the macroscopic findings. The chest 
tube was placed, the trocar removed and suction of 
- 30 mmHg applied. 
Pleurodesis was performed by the same procedure in the 
two groups i.e. by instillation in the pleural space of 500 mg 
tetracycline hydrochloride in 50 ml saline and 100 mg 
Bupivacain (Marcain@), the latter to reduce pleuritic pain. 
The catheter tube was then clamped for 6 hours, during 
which time the patient was instructed to change position at 
30 min intervals to ensure adequate dispersal. Thereafter 
suction of - 30 mmHg was applied and continued until 
efflux was less than 200 ml day- ‘. Then the catheter was 
removed. 
Data Analyses 
The data were evaluated with Student’s t test and Fisher’s 
exact test. A two-sided P level of 0.05 was considered as 
significant. The magnitude of a type 2 error was calculated 
to be 20% for a risk of overlooking a difference of 15% in 
the rate of successful pleurodesis. 
Results 
Twenty-one patients were included in the study. Eleven 
patients were randomized to treatment with the small 
catheter (Cystofix@) and ten were randomized to treatment 
with the conventional large-bore chest tube placed in con- 
nection with thoracoscopy. Of the former, two patients 
were excluded the day after: One had a small hydro- 
pneumothorax at the time of inclusion, which increased and 
required a large-bore chest tube. The other was found to be 
too weak to participate and died of cancer shortly after. 
One patient randomized for the large-bore chest tube 
changed her mind and wanted to be treated with the small 
catheter and was therefore excluded. Thus nine patients in 
each group were evaluable. Characteristics of these 18 
patients are presented in Table 1. There was no statistically 
significant difference between the two groups in terms of the 
variables shown. 
TABLE 1. Demographic data of the patients treated with 
pleurodesis with either a large bore chest tube or a small 
Cystofix@ catheter 
Large-bore 
chest tube Cystofix@ 
Number 9 9 
Male, female 6, 3 3, 6 
Age (years) 70.4 f 3.5 65.0 zt 3.6 
Thoracentesis I (ml) 1044.4 & 163.4 1375.0 f 168.8 
Thoracentesis II (ml) 1150.0 * 98.2 1185.7 f 206.4 
Thoracentesis III (ml) 975.0 f 131.5 1233.3 f 33.3 
The amount of pleural fluid before pleurodesis is shown 
(values given as mean Z!X SEM or absolute numbers). No 
significant differences between the two groups were found 
(PBO.05). 
TABLE 2. The patients’ evaluation of the insertion of the 
pleural catheter when compared with thoracentesis 
(number of patients is given) 
Large-bore 
chest tube Cystofix@ 
(A) Essentially more unpleasant 3 0 
(B) Somewhat more unpleasant 4 2 
(C) Not more unpleasant 2 7 
TABLE 3. The patients’ evaluation of the presence of the 
tube (number of patients is given) 
Large-bore 
chest tube Cystofix@ 
(A) Very unpleasant 2 0 
(B) Somewhat unpleasant 7 2 
(C) Not unpleasant 0 7 
The majority (seven of nine) did not find insertion of the 
small catheter more unpleasant than thoracentesis. In the 
group receiving the large catheter the opposite pattern was 
seen, since only a few (two of nine) found insertion com- 
parable with thoracentesis (Table 2, PcO.05). All patients 
found the presence of the large catheter very or somewhat 
unpleasant (two and seven patients), whereas this was 
only the case for a few (no and two patients) treated with 
the small catheter (Table 3, PcO.05). No significant 
difference was found between the groups concerning dis- 
comfort during performance of the pleurodesis (instillation 
of tetracycline) (Table 4). 
Of the patients treated with the large catheter (Table 5), 
complete roentgenographic response was observed in five 
patients. At week 3 partial response was seen in two 
TABLE 4. The patients’ evaluation of the instillation of 
tetracycline (number of patients is given) 
Large-bore 
chest tube cystofixs 
(A) Very unpleasant 1 1 
(B) Somewhat unpleasant 3 2 
(C) Not unpleasant 5 6 
patients. Of these, one patient was roentgenographically 
and clinically unchanged at week 6, but at week 9 the 
pleural fluid had increased. However the patient did not 
need or want a new thoracentesis. The other patient showed 
no roentgenographic response at week 6, and thoracentesis 
was performed. The remaining two of the nine patients 
showed no response to the pleurodesis and new thora- 
centesis was performed. Of the patients treated with the 
small catheter complete roentgenographic response was 
observed in six patients, partial response in one patient 
at week 3, which remained unchanged at week 7, and no 
response in two patients at week 3, in whom new thora- 
centesis was performed. 
Three patients in the latter group and one patient in the 
former group were not available for control at week 9 
because of transfer to local hospital or death (one patient) 
from the malignant disease (Table 5). However, these 
patients did not show any signs of failure of the pleurodesis. 
Four patients suffered from pleural mesothelioma judged 
by examination of the pleural fluid and of these the 
diagnosis was confirmed by thoracoscopy in two patients. 
The rest suffered from pleural adenocarcinoma. The three 
patients treated with the large catheter requiring new 
thoracentesis were all suffering from adenocarcinoma. Of 
the two patients with lack of effect of pleurodesis with 




Pleural fluid reaccumulates quickly in patients with malig- 
nant pleural disease. Therefore repeated thoracentesis is not 
sufficient and pleurodesis is needed. 
Different techniques have been described, e.g. mechanical 
abrasion or instillation of chemical agents in the pleural 
space (3-5). Agents used for pleurodesis include talc, gold, 
radioactive phosphorus, thiotepa, 5-fluorouracil, quina- 
crine, nitrogen mustard, doxorubicin, adriamycin, Coryne- 
bacterium parvum, bleomycin and tetracycline (6). 
Pleurodesis is traditionally performed with large-bore chest 
tubes and tetracycline as sclerosing agent (6). However, 
placement of the large-bore chest tube is a surgical pro- 
cedure that requires blunt dissection often resulting in pain 
and discomfort, during both placement and maintenance of 
the tube. We therefore examined whether pleurodesis could 
be performed with a small Cystofix’” catheter placed at 
bedside. 
The patients’ subjective opinions of the procedures have 
not previously been described. As expected, the question- 
naire showed that the small catheter was much better 
tolerated than the large catheter placed in connection with 
thoracoscopy for insertion, presence and instillation of 
tetracycline. Of course the thoracoscopy added to the 
distress in connection with insertion of the large-bore chest 
tube, but the patients’ evaluation of the presence of the tube 
or Cystofix catheter and the instillation of tetracycline 
could be compared without this bias. The pleurodesis was 
effective in approx. 70% of the patients in both groups, even 
in long-term follow-up, indicating an equal effect of the 
small Cystofix catheter and the large-bore chest tube. This 
result is in accordance with other studies evaluating tetra- 
cycline pleurodesis with small (7-9) or large (3) catheters. 
However, in these studies, the two catheters have not been 
compared prospectively. In one retrospective study a pigtail 
catheter seemed to be as successful as a standard chest 
tube (11). Tetracycline is often used in higher doses than 
the 500 mg we use [e.g. 1000-2000 mg (4,6,10)], but with 
success rates comparable with the rate in our study. A 
TABLE 5. Roentgenographic response to pleurodesis with either a large-bore chest tube or a 
Cystofixa catheter (number of patients is given) 
Large-bore 
chest tube Cystofix:‘< 
Week Week Week Week Week Week 
3 6 9 3 6 9 
Complete response 5 5 5 6 6 6 
Partial response 2 1 0 1 1 0 
No response 2 3 3 2 0 0 
Sum 9 9 8 9 7 6 
No significant difference between the two groups was found (P>O.O5). 
New thoracentesis was performed in three patients from the former group and two patients from the 
latter group. 
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prospective comparison of different doses has not been 
performed. 
No complications were seen (occlusion of catheter, 
empyema, pneumothorax, emphysema). Pneumothorax 
after small-bore catheter placement for malignant pleural 
effusions has been recognized by some authors as rare 
(10%) (10) or common (19-36%) (6,8,1 l), even when the 
catheters were sonographically inserted (6), whereas other 
authors do not mention this complication (7). 
Insertion of the Cystofix catheter was relatively painless, 
the presence of the catheter was well tolerated, there were 
no complications and the outcome compared favourably 
with that of large-bore chest tubes. We therefore conclude 
that the Cystofix@ catheter is comfortable, safe and effec- 
tive for pleurodesis in patients with malignant pleural 
effusion. 
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